Advanced Medical Solutions Grp PLC Notice of Preliminary Results (6678V)

TIDMAMS

RNS Number : 6678V

Advanced Medical Solutions Grp PLC

01 February 2017

01 February 2017

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Notice of Preliminary Results

Winsford, UK, 01 February: Advanced Medical Solutions Group plc (AIM: AMS.L), the surgical and advanced wound care specialist company, will announce its preliminary results for the year ended 31 December 2016 on Tuesday 14 March 2017.

A briefing for analysts will be held at 9.30am on the day of results. Please contact Consilium Strategic Communications for further details.

- Ends -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group         Tel: +44 (0) 
  plc                                      1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Group Finance Director 
 
 Consilium Strategic Communications       Tel: +44 (0) 
                                          20 3709 5700 
 Mary-Jane Elliott / Jonathan 
  Birt / Matthew Neal / Hendrik 
  Thys 
 
 Investec Bank PLC (NOMAD & Broker)       Tel: +44 (0) 
                                          20 7597 5970 
 Daniel Adams / Patrick Robb 
 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 530 employees. For more information please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOREAAFFDEXXEAF

(END) Dow Jones Newswires

February 01, 2017 02:00 ET (07:00 GMT)